The simulation hypothesis—the idea that our universe might be an artificial construct running on some advanced alien computer ...

A new research paper reframes the simulation hypothesis, asking whether reality could be simulated and what science can test.

Cornered in a part of Downtown Los Angeles swamped in contemporary art museums and performance centers, REDCAT has become a ...

Since the 2000s, Google Search—and later YouTube and Discover—served as the primary discovery and monetization engines for ...

The lack of gains in productivity from AI could stall adoption and burst the economic bubble. Is there a rational explanation?

A steaming bowl of pho becomes the most vivid thing in your visual field – the clear amber broth, bright green herbs, ruby red sriracha swirls, and sunny yellow lime wedges appearing almost ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

anthropomorphism: When humans tend to give nonhuman objects humanlike characteristics. In AI, this can include believing a ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...